DK3621963T3 - Forbindelser til behandling af epilepsi, neurodegenerative lidelser og andre CNS-lidelser - Google Patents
Forbindelser til behandling af epilepsi, neurodegenerative lidelser og andre CNS-lidelser Download PDFInfo
- Publication number
- DK3621963T3 DK3621963T3 DK18728316.3T DK18728316T DK3621963T3 DK 3621963 T3 DK3621963 T3 DK 3621963T3 DK 18728316 T DK18728316 T DK 18728316T DK 3621963 T3 DK3621963 T3 DK 3621963T3
- Authority
- DK
- Denmark
- Prior art keywords
- disorders
- epilepsy
- compounds
- treatment
- cns
- Prior art date
Links
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 206010015037 epilepsy Diseases 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17170674 | 2017-05-11 | ||
| PCT/EP2018/062199 WO2018206760A1 (en) | 2017-05-11 | 2018-05-11 | Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3621963T3 true DK3621963T3 (da) | 2024-04-15 |
Family
ID=58701546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18728316.3T DK3621963T3 (da) | 2017-05-11 | 2018-05-11 | Forbindelser til behandling af epilepsi, neurodegenerative lidelser og andre CNS-lidelser |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11548881B2 (da) |
| EP (1) | EP3621963B1 (da) |
| JP (1) | JP7158466B2 (da) |
| CN (1) | CN110650955B (da) |
| AU (1) | AU2018265478B2 (da) |
| CA (1) | CA3060481C (da) |
| DK (1) | DK3621963T3 (da) |
| EA (1) | EA201992397A1 (da) |
| ES (1) | ES2977619T3 (da) |
| PL (1) | PL3621963T3 (da) |
| WO (1) | WO2018206760A1 (da) |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005723A1 (en) | 1988-11-24 | 1990-05-31 | Yoshitomi Pharmaceutical Industries, Ltd. | Trans-4-amino(alkyl)-1-pyridylcarbamoyl-cyclohexane compounds and their medicinal use |
| IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| PT721331E (pt) | 1993-10-01 | 2002-05-31 | Astrazeneca Ab | Processo i |
| US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| WO1999033795A1 (en) | 1997-12-24 | 1999-07-08 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| SK9672000A3 (en) | 1997-12-24 | 2001-04-09 | Vertex Pharmaceuticals Inc Ver | Prodrugs of aspartyl protease inhibitors |
| AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US20040242673A1 (en) | 2003-05-16 | 2004-12-02 | Ambit Biosciences Corporation | Heterocyclic compounds and uses thereof |
| US20050182125A1 (en) | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
| WO2006110918A1 (en) * | 2005-04-13 | 2006-10-19 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
| EP2002834A1 (de) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors |
| EP2203427A2 (en) | 2007-09-20 | 2010-07-07 | Abbott Healthcare Products B.V. | 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| EP2149552A1 (de) * | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| BR112012014807A2 (pt) | 2009-12-16 | 2017-06-27 | Neuropore Therapies Inc | "compostos adequados para o tratamento de sinucleopatias" |
| CA2915975A1 (en) * | 2013-06-26 | 2014-12-31 | Proteostasis Therapeutics, Inc. | Methods of modulating cftr activity |
| WO2018206757A1 (en) | 2017-05-11 | 2018-11-15 | Remynd N.V. | Inhibitors of pde6delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders |
-
2018
- 2018-05-11 EA EA201992397A patent/EA201992397A1/ru unknown
- 2018-05-11 CN CN201880030677.6A patent/CN110650955B/zh active Active
- 2018-05-11 CA CA3060481A patent/CA3060481C/en active Active
- 2018-05-11 EP EP18728316.3A patent/EP3621963B1/en active Active
- 2018-05-11 ES ES18728316T patent/ES2977619T3/es active Active
- 2018-05-11 AU AU2018265478A patent/AU2018265478B2/en active Active
- 2018-05-11 DK DK18728316.3T patent/DK3621963T3/da active
- 2018-05-11 PL PL18728316.3T patent/PL3621963T3/pl unknown
- 2018-05-11 JP JP2020512915A patent/JP7158466B2/ja active Active
- 2018-05-11 US US16/612,096 patent/US11548881B2/en active Active
- 2018-05-11 WO PCT/EP2018/062199 patent/WO2018206760A1/en unknown
-
2022
- 2022-11-22 US US18/058,109 patent/US11939324B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11548881B2 (en) | 2023-01-10 |
| JP7158466B2 (ja) | 2022-10-21 |
| WO2018206760A1 (en) | 2018-11-15 |
| US20200095238A1 (en) | 2020-03-26 |
| US20230099111A1 (en) | 2023-03-30 |
| ES2977619T3 (es) | 2024-08-27 |
| US11939324B2 (en) | 2024-03-26 |
| EP3621963B1 (en) | 2024-01-24 |
| EA201992397A1 (ru) | 2020-03-16 |
| EP3621963A1 (en) | 2020-03-18 |
| JP2020519692A (ja) | 2020-07-02 |
| PL3621963T3 (pl) | 2024-05-20 |
| CN110650955A (zh) | 2020-01-03 |
| CN110650955B (zh) | 2023-07-25 |
| AU2018265478A1 (en) | 2019-11-07 |
| CA3060481A1 (en) | 2018-11-15 |
| AU2018265478B2 (en) | 2022-05-12 |
| CA3060481C (en) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3728284T3 (da) | 19-homo, 3.alpha.-hydroxy-steroid-20-on forbindelser til behandling af cns-lidelser | |
| DK3250210T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
| DK3206493T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
| DK3224269T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
| DK3277815T3 (da) | Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser | |
| DK3261640T3 (da) | 5ht-agonister til behandling af epilepsilidelser | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3600270T3 (da) | Forbindelser og sammensætninger til behandling af hæmatologiske lidelser | |
| DK3340981T3 (da) | Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser | |
| DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
| DK3294865T3 (da) | Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider | |
| DK3288577T3 (da) | Adiponectin-peptidomimetika til behandling af øjenlidelser | |
| DK3347015T3 (da) | Fremgangsmåder til diagnosticering og behandling af adfærdsforstyrrelser | |
| DK3256466T3 (da) | 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser | |
| DK3558280T3 (da) | Forebyggelse og behandling af migræne | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3452583T3 (da) | Konstruerede nukleaser, der er nyttige til behandling af hæmofili a | |
| DK3432895T3 (da) | Blodpladepelletlysat til anvendelse til behandling af neurologiske forstyrrelser | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3122743T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme |